United States· US:85248-013_496a7c75-cac6-f152-e063-6394a90a5ce4
Gethorey MIRACLE BALM
A medicinal product containing .alpha.-tocopherol; hyaluronic acid, registered in United States by Jiangxi Yudexi Pharmaceutical Co., LTD.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- .ALPHA.-TOCOPHEROL; HYALURONIC ACID
- Manufacturer
- Jiangxi Yudexi Pharmaceutical Co., LTD
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1185248-013-01
- ndc11852480130150 mL in 1 BOTTLE (85248-013-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7c33fc46-dbff-4671-ac1d-4347a4968235 GET /v1/drugs/7c33fc46-dbff-4671-ac1d-4347a4968235?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".5; 1",
"substance": ".ALPHA.-TOCOPHEROL; HYALURONIC ACID",
"productndc": "85248-013",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/100mL; g/100mL",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about .alpha.-tocopherol; hyaluronic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.